Iveric Bio Announces Foveal Anatomy Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura^® in Patients with Geographic Atrophy

IVERIC Bio, Inc. announced a post-hoc analysis which evaluated various Geographic Atrophy (GA) growth parameters to explore the rate of disease progression within various regions in the fovea in a subset of patients from the GATHER1 Zimura^® Phase III clinical trial for the treatment of GA.